G12C inhibitors in metastatic colorectal cancer: a tale of two targets.

Julia Martínez-Pérez, Manuel Valladares-Ayerbes
Author Information
  1. Julia Martínez-Pérez: Medical Oncology Department, University Hospital Virgen del Rocio, Seville, Spain.
  2. Manuel Valladares-Ayerbes: Medical Oncology Department, University Hospital Virgen del Rocio, Seville, Spain. ORCID

Abstract

No abstract text available.

Keywords

References

  1. Nat Med. 2024 Jan;30(1):271-278 [PMID: 38052910]
  2. Lancet Oncol. 2022 Jan;23(1):115-124 [PMID: 34919824]
  3. J Clin Oncol. 2021 Feb 1;39(4):273-284 [PMID: 33503393]
  4. N Engl J Med. 2020 Sep 24;383(13):1207-1217 [PMID: 32955176]
  5. N Engl J Med. 2023 Dec 7;389(23):2125-2139 [PMID: 37870968]
  6. Lancet. 2013 Jan 26;381(9863):303-12 [PMID: 23177514]
  7. N Engl J Med. 2023 May 4;388(18):1657-1667 [PMID: 37133585]
  8. Nature. 2019 Nov;575(7781):217-223 [PMID: 31666701]
  9. Front Oncol. 2022 Feb 16;12:826073 [PMID: 35251991]
  10. N Engl J Med. 2021 Jan 14;384(2):185-187 [PMID: 33497555]
  11. Oncologist. 2022 Aug 5;27(8):663-674 [PMID: 35472176]
  12. Cancer Discov. 2020 Aug;10(8):1129-1139 [PMID: 32430388]
  13. Lancet. 2023 Jul 1;402(10395):41-53 [PMID: 37331369]
  14. Nat Med. 2024 Jan;30(1):265-270 [PMID: 38177853]
  15. Cell Rep. 2022 Jun 21;39(12):110993 [PMID: 35732135]
  16. N Engl J Med. 2023 Aug 24;389(8):710-721 [PMID: 37611121]
  17. JCO Precis Oncol. 2021 Apr 06;5: [PMID: 34250391]
  18. Cancer Discov. 2018 Apr;8(4):428-443 [PMID: 29431699]
  19. N Engl J Med. 2023 Jan 5;388(1):44-54 [PMID: 36546659]
  20. N Engl J Med. 2015 May 14;372(20):1909-19 [PMID: 25970050]

Word Cloud

Created with Highcharts 10.0.0G12Ccolorectalinhibitorsmetastaticcancer:taletwotargetsKRASMetastaticcancermCRCRAS-mutantepidermalgrowthfactorreceptorEGFRtargettherapy

Similar Articles

Cited By

No available data.